Skip to main content
. 2017 Jul 15;8(7):381–389. doi: 10.4239/wjd.v8.i7.381

Table 8.

Insulin dose (U/d) before and after autologous bone marrow derived stem cell therapy in Group II

Patient Baseline 3 mo 6 mo 12 mo
1 40 27 16 12
2 46 44 38 34
3 25 18 8 5
4 30 20 20 18
5 40 34 30 -
6 55 40 - -
7 45 27 - -
Mean ± SE 40 ± 4 30 ± 4 22 ± 5
P value 0.003 0.01